# Novo Nordisk invests 8 billion DKK in expansion of Montes Claros production site in Brazil

Novo Nordisk announced an 8 billion DKK (6.4 billion reais) investment to expand its production site in Montes Claros, Brazil, adding aseptic production processes, a warehouse, and a quality control laboratory. Construction has begun and is expected to be completed in 2028, creating 600 permanent jobs.

- Type: Expansion
- Announced: 2025-04-07
- Where: Montes Claros, Brazil
- Value: $1.19B (8.00B DKK)
- Jobs: 600
- Starts operating: 2028
- Status: under construction
- Products: injectable treatments for obesity and chronic diseases, GLP-1 products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [novonordisk.com](https://www.novonordisk.com/news-and-media/latest-news/production-expansion-montes-claros-brazil.html), 2025-04-07: "With this expansion of the Montes Claros site we further strengthen our global production capacity, supporting our ability to meet current and future demand for innovative medicines around the world."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.